OCUL EBITDA Margin
Ocular Therapeutix Inc · EBITDA Margin
OCUL EBITDA Margin
Latest reported-546.73%period ending
OCUL TTM EBITDA Margin (-60688.89% → -546.73%)
TTM ebitda margin
High-resolution chart · PNG
OCUL ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -546.7284% | |
| -527.011% | |
| -480.8031% | |
| -418.6544% | |
| -353.8419% | |
| -295.6678% | |
| -276.4242% | |
| -253.7768% | |
| -196.1029% | |
| -164.1439% | |
| -113.646% | |
| -96.1778% | |
| -148.7033% | |
| -154.1622% | |
| -120.2222% | |
| -101.1583% | |
| -47.103% | |
| -26.7553% | |
| 5.8363% | |
| -205.0698% | |
| -289.7692% | |
| -548.8977% | |
| -839.4817% | |
| -701.9821% | |
| -1,284.7033% | |
| -1,285.5612% | |
| -1,839.1531% | |
| -2,854.3838% | |
| -3,181.0168% | |
| -2,734.3137% | |
| -2,811.7085% | |
| -2,615.0025% | |
| -2,611.3614% | |
| -3,202.6846% | |
| -3,113.3125% | |
| -3,078.377% | |
| -2,856.181% | |
| -2,485.5042% | |
| -2,242.1304% | |
| -2,220.3642% | |
| -2,395.6349% | |
| -2,289.9551% | |
| -2,139.6% | |
| -1,910.4453% | |
| -1,992.6288% | |
| -2,309.5645% | |
| -3,494.4301% | |
| -8,570.412% | |
| -15,679.8387% | |
| -60,688.8889% |